Male Pattern Baldness in Relation to Prostate Cancer-Specific Mortality: A Prospective Analysis in the NHANES I Epidemiologic Follow-up Study

American Journal of Epidemiology
Cindy Ke ZhouM B Cook

Abstract

We used male pattern baldness as a proxy for long-term androgen exposure and investigated the association of dermatologist-assessed hair loss with prostate cancer-specific mortality in the first National Health and Nutrition Examination Survey Epidemiologic Follow-up Study. From the baseline survey (1971-1974), we included 4,316 men who were 25-74 years of age and had no prior cancer diagnosis. We estimated hazard ratios and used Cox proportional hazards regressions with age as the time metric and baseline hazard stratified by baseline age. A hybrid framework was used to account for stratification and clustering of the sample design, with adjustment for the variables used to calculate sample weights. During follow-up (median, 21 years), 3,284 deaths occurred; prostate cancer was the underlying cause of 107. In multivariable models, compared with no balding, any baldness was associated with a 56% higher risk of fatal prostate cancer (hazard ratio = 1.56; 95% confidence interval: 1.02, 2.37), and moderate balding specifically was associated with an 83% higher risk (hazard ratio = 1.83; 95% confidence interval: 1.15, 2.92). Conversely, patterned hair loss was not statistically significantly associated with all-cause mortality. Our...Continue Reading

References

Sep 1, 1991·American Journal of Public Health·E L Korn, B I Graubard
Dec 1, 1974·The Journal of Clinical Endocrinology and Metabolism·H U Schweikert, J D Wilson
Aug 1, 1974·Journal of the National Cancer Institute·P GreenwaldA K Polan
Apr 1, 1994·Baillière's Clinical Endocrinology and Metabolism·M N PattersonI A Hughes
Apr 1, 1996·American Journal of Epidemiology·E S FordT Byers
Jan 1, 1997·American Journal of Epidemiology·E L KornD Midthune
Feb 27, 1999·International Journal of Cancer. Journal International Du Cancer·C C HsiehD Trichopoulos
Jun 23, 2001·Molecular and Cellular Endocrinology·A O Brinkmann
Dec 6, 2001·Journal of the National Cancer Institute·D F PensonJ L Stanford
Dec 17, 2003·The Journal of Investigative Dermatology·Dale R NyholtNicholas G Martin
Feb 6, 2004·Journal of Dermatological Science·Hyo Jung BangBong Chul Chung
Mar 1, 1951·Annals of the New York Academy of Sciences·J B HAMILTON
Dec 22, 2005·Frontiers in Bioscience : a Journal and Virtual Library·Ann W Hsing, Anand P Chokkalingam
Oct 10, 2006·Clinical Colorectal Cancer·G Kesava ReddyPreeta Tyagi
Jan 4, 2008·International Journal of Cancer. Journal International Du Cancer·Jocelyn M WeissRichard B Hayes
Jan 31, 2008·Journal of the National Cancer Institute·UNKNOWN Endogenous Hormones and Prostate Cancer Collaborative GroupTimothy J Key
Jan 28, 2009·The Aging Male : the Official Journal of the International Society for the Study of the Aging Male·Gökhan FaydaciKuyumcuoğlu Uğur
Mar 9, 2010·Cancer Epidemiology·Jonathan L WrightJanet L Stanford
Jun 22, 2010·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Ruben G CremersLambertus A Kiemeney
Jul 14, 2010·Journal of the American Academy of Dermatology·Salvador Arias-SantiagoRamón Naranjo-Sintes
Feb 18, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M YassaP Giraud
Oct 18, 2012·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·David C MullerGianluca Severi
Feb 1, 2013·Nature Reviews. Cancer·Siobhan Sutcliffe, Graham A Colditz
Feb 12, 2013·Journal of the American Academy of Dermatology·Aline AmorettiWilma Bergfeld
Mar 28, 2013·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Charnita Zeigler-JohnsonTimothy R Rebbeck
Jan 21, 2014·European Urology·Stacy LoebRuth Etzioni
Sep 17, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Cindy Ke ZhouMichael B Cook

❮ Previous
Next ❯

Citations

Feb 15, 2017·PLoS Genetics·Saskia P HagenaarsRiccardo E Marioni
Mar 14, 2018·International Journal of Cancer. Journal International Du Cancer·Úna C Mc MenaminChris R Cardwell
Nov 18, 2017·Nature Communications·Nicola PirastuJames F Wilson
Nov 29, 2017·Archives of Dermatological Research·Cristina FortesA Panebianco
Nov 16, 2017·Cancer Causes & Control : CCC·Nathan P PapaGraham G Giles
Apr 12, 2020·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Saud KhanSarah C Markt

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.